UnitedHealth Group (UNH) to Release Earnings on Thursday

UnitedHealth Group (NYSE:UNH) is projected to release its earnings data before the market opens on Thursday, April 17th. Analysts expect UnitedHealth Group to post earnings of $7.24 per share and revenue of $111.56 billion for the quarter. UnitedHealth Group has set its FY25 guidance at $29.50-30.00 EPS.Investors that wish to register for the company’s conference call can do so using this link.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 earnings per share. On average, analysts expect UnitedHealth Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

UnitedHealth Group Price Performance

UNH stock opened at $580.16 on Thursday. UnitedHealth Group has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a market cap of $530.68 billion, a price-to-earnings ratio of 37.43, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a 50 day simple moving average of $510.86 and a 200 day simple moving average of $541.73.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.45%. UnitedHealth Group’s payout ratio is 54.19%.

Analysts Set New Price Targets

A number of analysts have weighed in on UNH shares. Mizuho increased their price target on UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday. Wells Fargo & Company lowered their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Finally, Truist Financial decreased their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Twenty-one research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $630.35.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.33% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

A hedge fund recently raised its stake in UnitedHealth Group stock. Brighton Jones LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 176.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 44,249 shares of the healthcare conglomerate’s stock after acquiring an additional 28,231 shares during the period. UnitedHealth Group comprises 0.6% of Brighton Jones LLC’s investment portfolio, making the stock its 24th biggest position. Brighton Jones LLC’s holdings in UnitedHealth Group were worth $22,384,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.